Skip to main content

Advertisement

Log in

Susceptibilities to Amphotericin B, Fluconazole and Voriconazole of Trichosporon Clinical Isolates

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

A total of 35 Trichosporon isolates were collected from the Taiwan Surveillance of Antimicrobial Resistance of Yeasts (TSARY) project from 1999 to 2006, and their identifications as well as drug susceptibilities were determined. The most frequently isolated species was T. asahii (62.9%), and the most common clinical sample that yielded Trichosporon isolates was urine (37.1%). The etiology of all seven invasive trichosporonosis was T. asahii. For the 22 T. asahii isolates, the MIC50 and MIC90 for amphotericin B were 0.25 and 1 μg/mL, respectively. Those for fluconazole were 2 and 4 μg/mL, respectively, and for voriconazole 0.031 and 0.063 μg/mL, respectively. When the intraclass correlation coefficients (ICCs) and agreements were calculated, we found that the MICs of fluconazole obtained from different methods were similar and the inter-method discrepancies were low. Nevertheless, no unanimous MIC of amphotericin B and voriconazole was obtained among different methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yang YL, Cheng HH, Ho YA, Hsiao CF, Lo HJ. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect. 2003;36:187–91.

    PubMed  CAS  Google Scholar 

  2. Yang YL, Cheng MF, Wang CW, Wang AH, Cheng WT, Lo HJ, et al. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Med Mycol. 2010;48:328–34.

    Article  PubMed  CAS  Google Scholar 

  3. Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol. 2004;25:60–4.

    Article  PubMed  CAS  Google Scholar 

  4. Yang YL, Li SY, Cheng HH, Lo HJ. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis. 2005;51:179–83.

    Article  PubMed  CAS  Google Scholar 

  5. Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, et al. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2006. Diagn Microbiol Infect Dis. 2008;61:175–80.

    Article  PubMed  CAS  Google Scholar 

  6. Colombo AL, Padovan AC, Chaves GM. Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev. 2011;24:682–700.

    Article  PubMed  CAS  Google Scholar 

  7. Ellner K, McBride ME, Rosen T, Berman D. Prevalence of Trichosporon beigelii. Colonization of normal perigenital skin. J Med Vet Mycol. 1991;29:99–103.

    Article  PubMed  CAS  Google Scholar 

  8. Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol. 2009;47:1074–81.

    Article  PubMed  CAS  Google Scholar 

  9. Hajjeh RA, Blumberg HM. Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy. Clin Infect Dis. 1995;20:913–6.

    Article  PubMed  CAS  Google Scholar 

  10. Tashiro T, Nagai H, Kamberi P, Goto Y, Kikuchi H, Nasu M, et al. Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review. Eur J Clin Microbiol Infect Dis. 1994;13:218–24.

    Article  PubMed  CAS  Google Scholar 

  11. Walsh TJ. Trichosporonosis. Infect Dis Clin North Am. 1989;3:43–52.

    PubMed  CAS  Google Scholar 

  12. Guo LN, Xiao M, Kong F, Chen SC, Wang H, Sorrell TC, et al. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. J Clin Microbiol. 2011;49:3805–11.

    Article  PubMed  CAS  Google Scholar 

  13. Li HM, Du HT, Liu W, Wan Z, Li RY. Microbiological characteristics of medically important Trichosporon species. Mycopathologia. 2005;160:217–25.

    Article  PubMed  Google Scholar 

  14. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother. 2005;49:4026–34.

    Article  PubMed  CAS  Google Scholar 

  15. Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis. 2009;49:e11–7.

    Article  PubMed  CAS  Google Scholar 

  16. Clinical Laboratory Standards Institute CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. CLSI document M27-A3. Wayne, PA; 2008.

  17. Testing SoASTotEECfAS. Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing: EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect. 2008;14:982–4.

    Article  Google Scholar 

  18. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1:30–46.

    Article  Google Scholar 

  19. Lo HJ, Ho AH, Ho M. Factors accounting for mis-identification of Candida species. J Microbiol Immunol Infect. 2001;34:171–7.

    PubMed  CAS  Google Scholar 

  20. Leaw SN, Chang HC, Barton R, Bouchara JP, Chang TC. Identification of medically important Candida and non-Candida yeast species by an oligonucleotide array. J Clin Microbiol. 2007;45:2220–9.

    Article  PubMed  CAS  Google Scholar 

  21. Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol. 2006;44:693–9.

    Article  PubMed  CAS  Google Scholar 

  22. Kalkanci A, Sugita T, Arikan S, Yucesoy M, Ener B, Otag F, et al. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med Mycol. 2010;48:141–6.

    Article  PubMed  CAS  Google Scholar 

  23. Nakajima M, Sugita T, Mikami Y. Granuloma associated with Trichosporon asahii infection in the lung: Unusual pathological findings and PCR detection of Trichosporon DNA. Med Mycol. 2007;45:641–4.

    Article  PubMed  CAS  Google Scholar 

  24. Taj-Aldeen SJ, Al-Ansari N, El Shafei S, Meis JF, Curfs-Breuker I, Theelen B, et al. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J Clin Microbiol. 2009;47:1791–9.

    Article  PubMed  CAS  Google Scholar 

  25. Girmenia C, Pagano L, Martino B, D’Antonio D, Fanci R, Specchia G, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43:1818–28.

    Article  PubMed  Google Scholar 

  26. Suzuki K, Nakase K, Kyo T, Kohara T, Sugawara Y, Shibazaki T, et al. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol. 2010;84:441–7.

    Article  PubMed  Google Scholar 

  27. Bayramoglu G, Sonmez M, Tosun I, Aydin K, Aydin F. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection. 2008;36:68–70.

    Article  PubMed  CAS  Google Scholar 

  28. Araujo Ribeiro M, Alastruey-Izquierdo A, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Rev Iberoam Micol. 2008;25:221–5.

    Article  PubMed  Google Scholar 

  29. McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR Jr, Rinaldi MG. In vitro activity of voriconazole against selected fungi. Med Mycol. 1998;36:239–42.

    PubMed  CAS  Google Scholar 

  30. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother. 2002;46:1144–6.

    Article  PubMed  CAS  Google Scholar 

  31. Perparim K, Nagai H, Hashimoto A, Goto Y, Tashiro T, Nasu M. In vitro susceptibility of Trichosporon beigelii to antifungal agents. J Chemother. 1996;8:445–8.

    PubMed  CAS  Google Scholar 

  32. Uzun O, Arikan S, Kocagoz S, Sancak B, Unal S. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn Microbiol Infect Dis. 2000;38:101–7.

    Article  PubMed  CAS  Google Scholar 

  33. Thompson GR III, Wiederhold NP, Sutton DA, Fothergill A, Patterson TF. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species. J Antimicrob Chemother. 2009;64:79–83.

    Article  PubMed  CAS  Google Scholar 

  34. Febre N, Silva V, Medeiros EA, Wey SB, Colombo AL, Fischman O. Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization. J Clin Microbiol. 1999;37:1584–6.

    PubMed  CAS  Google Scholar 

  35. Mori Y, Hiraoka M, Katsu M, Tsukahara H, Mikami Y, Mayumi M. Marked renal damage in a child with hydronephrosis infected by Trichosporon asahii. Pediatr Nephrol. 2005;20:234–6.

    Article  PubMed  Google Scholar 

  36. Wolf DG, Falk R, Hacham M, Theelen B, Boekhout T, Scorzetti G, et al. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol. 2001;39:4420–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Bristol Myers Squibb for supplying the reference powder of amphotericin B, and Pfizer for fluconazole and voriconazole. They also thank the TSARY hospitals, especially the following 17, for providing clinical Trichosporon isolates: Chang Gung Memorial Hospital at Keelung, Chang Gung Memorial Hospital at Linkou, Chi-Mei Foundation Hospital, Chung Shan Medical Dental College Hospital, Tainan Municipal Hospital, Kuan-Tien General Hospital, Lo-Hsu Foundation Inc. Lo-Tung Poh Ai Hospital, Kaohsiung Military Hospital, Hua-Lien Mennonite Church Hospital, National Cheng-Kung University Hospital, Hua-Lien Hospital, DOH, the Executive Yuan, Show Chwan Memorial Hospital, Tri Service General Hospital, Veterans General Hospital—Taichung, Veterans General Hospital-Kaohsiung, Asia East Memorial Hospital, and Buddhist Tzu-Chi General Hospital. This work was supported in part by the NHRI fellowship research grant to MST and by grants CL-098-PP-04 and ID-099-PP-04 from the NHRI to HJL.

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hsiu Jung Lo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsai, M.S., Yang, Y.L., Wang, A.H. et al. Susceptibilities to Amphotericin B, Fluconazole and Voriconazole of Trichosporon Clinical Isolates. Mycopathologia 174, 121–130 (2012). https://doi.org/10.1007/s11046-012-9525-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-012-9525-z

Keywords

Navigation